Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study With GFT505 (80mg) in Patients With Insulin Resistance and Abdominal Obesity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Waist circumference ≥94cm.~* Body Mass Index ≤ 45kg/m2.~* Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) \> 3.~Exclusion Criteria:~* Blood Pressure \> 160 / 95 mmHg.~* Diabetes mellitus 1 or 2.~* Historical of bariatric surgery.~* Patient treated with a lipid-decreasing medication.~* A fasting plasma triglycerides concentration \> 400mg/dL or a plasma Low Density Lipoprotein Cholesterol (LDL-c)concentration \> 220mg/dL.

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- GFT505 80mg (Type: EXPERIMENTAL): None
- Matching placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).